S&P rates Houston Methodist Hospital’s bonds

S&P has assigned an “AA” long-term rating to $300 million of fixed rate series 2015 hospital revenue bonds issued on behalf of Methodist Hospital, which does business as Houston Methodist Hospital.

Advertisement

The rating “reflects our view of such factors as Methodist’s very strong business position, successful past expansions, remarkably high operational liquidity and very strong cash flow,” said Kevin Holloran, an S&P credit analyst.

The bond proceeds will be used to help fund various capital projects.

More articles on healthcare finance:

CMS proposes changes to Physician Fee Schedule: 15 things to know
45 states earn ‘F’ grades for healthcare price transparency
Why CFO roles are being filled by Gen Xers

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.